bf/NASDAQ:AZN_icon.jpeg

NASDAQ:AZN

AstraZeneca plc

  • Stock

USD

Last Close

75.80

03/05 17:39

Market Cap

208.00B

Beta: 0.17

Volume Today

3.77M

Avg: 4.68M

PE Ratio

34.25

PFCF: 28.96

Dividend Yield

2.22%

Payout:75.97%

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
3.27B
-
1.25B
61.86%
3.07B
146.31%
3.55B
15.74%
2.23B
37.30%
1.99B
10.51%
1.55B
22.33%
3.92B
152.97%
-265M
106.77%
2.50B
1,043.77%
6.90B
175.85%
depreciation and amortization
4.58B
-
3.28B
28.39%
2.85B
13.10%
2.36B
17.36%
3.04B
28.81%
3.75B
23.62%
3.76B
0.24%
3.15B
16.29%
6.53B
107.37%
5.48B
16.08%
4.93B
9.96%
deferred income tax
-259M
-
-277M
6.95%
-615M
122.02%
-619M
0.65%
stock based compensation
259M
-
277M
6.95%
615M
122.02%
619M
0.65%
change in working capital
166M
-
2.51B
1,410.84%
-49M
101.95%
926M
1,989.80%
-50M
105.40%
-639M
1,178%
-346M
45.85%
361M
204.34%
2.02B
459.83%
3.76B
85.90%
300M
92.01%
accounts receivables
-898M
-
-739M
17.71%
-961M
30.04%
-1.35B
40.37%
inventory
135M
-
108M
20%
-315M
391.67%
-343M
8.89%
-548M
59.77%
-13M
97.63%
-316M
2,330.77%
-621M
96.52%
1.58B
353.95%
3.94B
149.90%
-669M
116.98%
accounts payables
898M
-
739M
17.71%
961M
30.04%
1.35B
40.37%
other working capital
31M
-
2.40B
7,641.94%
266M
88.92%
1.27B
377.07%
498M
60.76%
-626M
225.70%
-30M
95.21%
982M
3,373.33%
444M
54.79%
-184M
141.44%
969M
626.63%
other non cash items
-616M
-
22M
103.57%
-2.55B
11,681.82%
-2.69B
5.57%
-1.64B
39.22%
-2.49B
52.23%
-2.00B
19.85%
-2.63B
31.68%
-2.32B
11.57%
-1.93B
16.92%
-1.79B
7.36%
net cash provided by operating activities
7.40B
-
7.06B
4.62%
3.32B
52.90%
4.14B
24.70%
3.58B
13.68%
2.62B
26.83%
2.97B
13.41%
4.80B
61.64%
5.96B
24.26%
9.81B
64.48%
10.35B
5.48%
investments in property plant and equipment
-2.06B
-
-2.75B
33.72%
-2.79B
1.31%
-2.31B
17.00%
-1.62B
29.99%
-1.37B
15.37%
-2.46B
79.43%
-2.61B
5.93%
-2.20B
15.58%
-2.57B
16.86%
-3.78B
46.95%
acquisitions net
-1.16B
-
-4.53B
291.28%
-3.07B
32.24%
-2.90B
5.60%
-1.96B
32.37%
-536M
72.65%
-783M
46.08%
-830M
6.00%
-9.43B
1,036.51%
-1.06B
88.75%
-1.18B
11.12%
purchases of investments
-91M
-
-130M
42.86%
-57M
56.15%
-396M
594.74%
-441M
11.36%
-102M
76.87%
-13M
87.25%
-119M
815.38%
-184M
54.62%
-159M
13.59%
-136M
14.47%
sales maturities of investments
168M
-
93M
44.64%
376M
304.30%
3M
99.20%
70M
2,233.33%
429M
512.86%
212M
50.58%
2.13B
902.83%
105M
95.06%
42M
60%
129M
207.14%
other investing activites
250M
-
288M
15.20%
1.30B
351.39%
1.64B
25.85%
1.62B
0.79%
2.54B
56.69%
2.39B
6.13%
1.14B
52.07%
654M
42.83%
789M
20.64%
900M
14.07%
net cash used for investing activites
-2.89B
-
-7.03B
143.41%
-4.24B
39.72%
-3.97B
6.37%
-2.33B
41.35%
963M
141.37%
-657M
168.22%
-285M
56.62%
-11.06B
3,780.00%
-2.96B
73.23%
-4.06B
37.30%
debt repayment
-5M
-
-750M
14,900%
-1.51B
101.87%
-303M
79.99%
-1.75B
477.56%
-1.50B
14.40%
-2.02B
34.58%
-1.61B
20.19%
-4.76B
195.77%
-1.27B
73.29%
-4.94B
288.83%
common stock issued
482M
-
279M
42.12%
43M
84.59%
47M
9.30%
43M
8.51%
34M
20.93%
3.52B
10,267.65%
30M
99.15%
29M
3.33%
29M
0%
33M
13.79%
common stock repurchased
-27M
-
1.40B
5,296.30%
5.89B
319.53%
2.78B
52.80%
2.31B
16.85%
2.97B
28.61%
314M
89.43%
3.05B
871.02%
12.41B
307.12%
-920M
107.41%
3.71B
503.15%
dividends paid
-3.46B
-
-3.52B
1.73%
-3.49B
0.99%
-3.56B
2.15%
-3.52B
1.18%
-3.48B
0.99%
-3.59B
3.10%
-3.57B
0.56%
-3.86B
7.95%
-4.36B
13.17%
-4.48B
2.68%
other financing activites
-36M
-
-116M
222.22%
-51M
56.03%
-285M
458.82%
-20M
92.98%
-67M
235%
4M
105.97%
-101M
2,625%
-178M
76.24%
-297M
66.85%
-886M
198.32%
net cash used provided by financing activities
-3.05B
-
-2.71B
11.22%
878M
132.46%
-1.32B
250.80%
-2.94B
121.75%
-2.04B
30.38%
-1.76B
13.65%
-2.20B
24.82%
3.65B
265.64%
-6.82B
286.98%
-6.57B
3.75%
effect of forex changes on cash
-65M
-
-152M
133.85%
-76M
50%
21M
127.63%
-66M
414.29%
-38M
42.42%
5M
113.16%
12M
140%
-62M
616.67%
-80M
29.03%
-60M
25%
net change in cash
1.40B
-
-2.83B
302.36%
-113M
96.01%
-1.13B
897.35%
-1.75B
55.46%
1.50B
185.56%
552M
63.18%
2.32B
320.83%
-1.51B
164.92%
-55M
96.35%
-346M
529.09%
cash at beginning of period
7.60B
-
8.99B
18.42%
6.16B
31.47%
6.05B
1.83%
4.92B
18.63%
3.17B
35.58%
4.67B
47.26%
5.22B
11.82%
7.55B
44.48%
6.04B
19.98%
5.98B
0.91%
cash at end of period
8.99B
-
6.16B
31.47%
6.05B
1.83%
4.92B
18.63%
3.17B
35.58%
4.67B
47.26%
5.22B
11.82%
7.55B
44.48%
6.04B
19.98%
5.98B
0.91%
5.64B
5.78%
operating cash flow
7.40B
-
7.06B
4.62%
3.32B
52.90%
4.14B
24.70%
3.58B
13.68%
2.62B
26.83%
2.97B
13.41%
4.80B
61.64%
5.96B
24.26%
9.81B
64.48%
10.35B
5.48%
capital expenditure
-2.06B
-
-2.75B
33.72%
-2.79B
1.31%
-2.31B
17.00%
-1.62B
29.99%
-1.37B
15.37%
-2.46B
79.43%
-2.61B
5.93%
-2.20B
15.58%
-2.57B
16.86%
-3.78B
46.95%
free cash flow
5.34B
-
4.31B
19.39%
536M
87.55%
1.83B
241.60%
1.96B
6.94%
1.25B
36.31%
509M
59.18%
2.19B
330.84%
3.76B
71.59%
7.24B
92.32%
6.57B
9.26%

All numbers in USD (except ratios and percentages)